Prediction of Treatment Efficacy and Telaprevir-Resistant Variants After Triple Therapy in Patients Infected With Hepatitis C Virus Genotype 1
Journal of Clinical Microbiology - United States
doi 10.1128/jcm.01129-13
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 19, 2013
Authors
Publisher
American Society for Microbiology